Effects of interval training on risk markers for arrhythmic death: a randomized controlled trial.


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 13 4 2019
medline: 14 11 2019
entrez: 13 4 2019
Statut: ppublish

Résumé

To compare the effects of high-intensity interval training versus moderate-intensity continuous training on risk markers of arrhythmic death in patients who recently suffered from an acute coronary syndrome. Double-blind (patient and evaluator) randomized controlled trial. Cardiovascular Prevention and Rehabilitation Centre (EPIC Centre) of the Montreal Heart Institute, Montreal, Canada. A total of 43 patients were randomized following an acute coronary syndrome. Patients were assigned to either high-intensity interval training (n = 18) or isocaloric moderate-intensity continuous training (n = 19), three times a week for a total of 36 sessions. Heart rate recovery for 5 minutes, heart rate variability for 24 hours, occurrence of ventricular arrhythmias, and QT dispersion were measured before and after the 36 sessions of training. Among the 43 patients randomized, 6 participants in the high-intensity interval training group stopped training for reasons unrelated to exercise training and were excluded from the analyses. Heart rate recovery improved solely in the high-intensity interval training group, particularly at the end of recovery period ( Despite the lack of power to detect any large difference between the two interventions with respect to risk markers of arrhythmic death, high-intensity interval training appears safe and may be more effective at improving heart rate recovery relative to moderate-intensity continuous training in our patients following acute coronary syndrome.

Identifiants

pubmed: 30977397
doi: 10.1177/0269215519840388
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1320-1330

Auteurs

Maxime Boidin (M)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
3 Department of Kinesiology, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Mathieu Gayda (M)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
4 Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Christine Henri (C)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
4 Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Doug Hayami (D)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
4 Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Lukas D Trachsel (LD)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
4 Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Florent Besnier (F)

5 Institute of Cardiovascular and Metabolic Diseases, National Institute of Health and Medical Research (INSERM), UMR-1048, Toulouse, France.
6 ELSAN and Clinic of Saint-Orens, Cardiovascular and Pulmonary Rehabilitation Centre, Saint-Orens-de-Gameville, France.

Julie Lalongé (J)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.

Martin Juneau (M)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
4 Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Anil Nigam (A)

1 Cardiovascular Prevention and Rehabilitation (EPIC) Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
2 Research Center, Montreal Heart Institute and University of Montreal, Montreal, QC, Canada.
4 Department of Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH